Chemed Corp
NYSE:CHE
Chemed Corp
NYSE:CHE
Price:
572.2201 USD
-1.4%
Updated:
May 8, 2024
Chemed Corp
Operating Income
|
Chemed Corp
Operating Income Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chemed Corp
NYSE:CHE
|
Operating Income
$373.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$13.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Chemed Corp's Operating Income?
Operating Income
373.4m
USD
373.4m
USD
Based on the financial report for Mar 31, 2024, Chemed Corp's Operating Income amounts to 373.4m USD.
What is Chemed Corp's Operating Income growth rate?
Operating Income CAGR 10Y
10%
10%
Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Chemed Corp have been 3% over the past three years , 9% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
